216 related articles for article (PubMed ID: 2600815)
21. Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets.
Endo T; Ogawa T; Hamaue N; Akita K; Hirafuji M; Minami M; Blower PR
Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):243-53. PubMed ID: 9730004
[TBL] [Abstract][Full Text] [Related]
22. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
Di Matteo V; Pierucci M; Esposito E
J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
[TBL] [Abstract][Full Text] [Related]
24. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
Prins NH; Briejer MR; Schuurkes JA
Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
[TBL] [Abstract][Full Text] [Related]
26. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
[TBL] [Abstract][Full Text] [Related]
27. Neuroactive steroid dehydroepiandrosterone sulfate inhibits 5-hydroxytryptamine (5-HT)-evoked glutamate release via activation of sigma-1 receptors and then inhibition of 5-HT3 receptors in rat prelimbic cortex.
Dong L; Zhu Y; Dong Y; Yang J; Zhao Y; Qi Y; Wu P; Zhu Y; Zheng P
J Pharmacol Exp Ther; 2009 Aug; 330(2):494-501. PubMed ID: 19420298
[TBL] [Abstract][Full Text] [Related]
28. Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption.
Yoshimoto K; Yayama K; Sorimachi Y; Tani J; Ogata M; Nishimura A; Yoshida T; Ueda S; Komura S
Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):311A-319A. PubMed ID: 8986229
[TBL] [Abstract][Full Text] [Related]
29. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization.
Iyer RN; Bradberry CW
J Pharmacol Exp Ther; 1996 Apr; 277(1):40-7. PubMed ID: 8613947
[TBL] [Abstract][Full Text] [Related]
30. Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum.
De Deurwaerdère P; L'hirondel M; Bonhomme N; Lucas G; Cheramy A; Spampinato U
J Neurochem; 1997 Jan; 68(1):195-203. PubMed ID: 8978726
[TBL] [Abstract][Full Text] [Related]
31. Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release.
Maura G; Carbone R; Raiteri M
J Pharmacol Exp Ther; 1989 Dec; 251(3):1142-6. PubMed ID: 2574740
[TBL] [Abstract][Full Text] [Related]
32. Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.
Mongeau R; De Montigny C; Blier P
Eur J Pharmacol; 1994 May; 256(3):269-79. PubMed ID: 8045271
[TBL] [Abstract][Full Text] [Related]
33. 5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade.
Saller CF; Czupryna MJ; Salama AI
J Pharmacol Exp Ther; 1990 Jun; 253(3):1162-70. PubMed ID: 2141636
[TBL] [Abstract][Full Text] [Related]
34. 5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats.
Ito C; Isobe Y; Tsuchida K; Higuchi S
Arch Int Pharmacodyn Ther; 1996; 331(2):203-18. PubMed ID: 8937630
[TBL] [Abstract][Full Text] [Related]
35. Central 5-hydroxytryptamine receptor-linked protein kinase C translocation: a functional postsynaptic signal transduction system.
Wang HY; Friedman E
Mol Pharmacol; 1990 Jan; 37(1):75-9. PubMed ID: 2300046
[TBL] [Abstract][Full Text] [Related]
36. Serotonin inhibits acetylcholine release from rat striatum slices: evidence for a presynaptic receptor-mediated effect.
Gillet G; Ammor S; Fillion G
J Neurochem; 1985 Dec; 45(6):1687-91. PubMed ID: 4056789
[TBL] [Abstract][Full Text] [Related]
37. Effect of the 5-hydroxytryptamine3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study.
Volonté M; Ceci A; Borsini F
J Pharmacol Exp Ther; 1995 Oct; 275(1):358-67. PubMed ID: 7562571
[TBL] [Abstract][Full Text] [Related]
38. Phorbol esters and D2-dopamine receptors.
Cubeddu LX; Lovenberg TW; Hoffman IS; Talmaciu RK
J Pharmacol Exp Ther; 1989 Nov; 251(2):687-93. PubMed ID: 2530340
[TBL] [Abstract][Full Text] [Related]
39. Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
Yoshioka M
J Pharmacol Exp Ther; 1989 Aug; 250(2):637-41. PubMed ID: 2527299
[TBL] [Abstract][Full Text] [Related]
40. Effect of 5-hydroxytryptamine on gastric motility and efferent gastric vagus nerve activity in rats.
Yoshioka M; Ikeda T; Togashi H; Saito Y; Saito H
Res Commun Chem Pathol Pharmacol; 1990 Oct; 70(1):3-10. PubMed ID: 2263761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
